Please assess the completion status of the following clinical trial:

Trial Title: Low Pain Prediction in Cesarean Section Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* anticipated pain level estimated to be in the lowest 20th percentile (calculated \<34.3 utilizing our standard preoperative questionnaire)~* age \>/= 18~* not allergic to any study medications to be utilized in this study~* singleton pregnancy~Exclusion Criteria:~* allergies to morphine or acetaminophen~* diagnosis of a chronic pain disorder~* weight \>300 lbs~* hepatic disease

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- duramorph (Type: ACTIVE_COMPARATOR): duramorph 150 mcg administered spinally with placebo capsules administered by mouth every 6 hours x 4 doses during first 24 hours
- no duramorph (Type: EXPERIMENTAL): no duramorph is administered spinally for surgery; subjects receive acetaminophen 1 G orally x 4 doses during first 24 hours postoperatively

Based on this trial design, predict the completion outcome and termination type (if applicable).